STOCK TITAN

DocuSign, Inc. (DOCU) Financials

DOCU
Trailing 12 months to July 31, 2026
Revenue $3.4B +8.6% YoY
Net Income $330.0M +17.4% YoY
EPS (Diluted) $1.64 +23.3% YoY
Free Cash Flow $1.2B +28.1% YoY
Market Cap $13.3B as of Oct 9, 2026
Price / Sales 4.0x on $3.4B revenue, trailing 12 months to July 31, 2026
Price / Earnings 40.3x on $330.0M net income, trailing 12 months to July 31, 2026
Price / Book 7.7x on $1.7B equity, Q2 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 9, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2027, ended Jul 31, 2026 Reported Currency USD FYE January

Newest figures come from the 10-Q for Q2 FY2027, filed Sep 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DOCU SEC filings page.

DocuSign, Inc. (DOCU) reported $3.4B in revenue over the twelve months to Jul 31, 2026, up 8.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DOCU FY2026

DocuSign is turning steady high-margin growth into cash, while buybacks and rising current liabilities tighten its short-term balance-sheet cushion.

FY2025’s reported net income included a $819.9M tax benefit, so its earnings spike was not operating-driven; FY2026’s cash generation reached $1.2B even as net income normalized. The gap between $1.2B of operating cash flow and $309M of net income indicates accounting profit understates cash produced in the latest year, although cash conversion should not be equated with recurring earnings.

From FY2022 to FY2026, operating margin swung from -2.9% to 9.3% while gross margin remained broadly stable, so the improvement came primarily from operating-cost absorption rather than a higher gross-profit rate. That marks a shift from strong gross economics being consumed by overhead to more of each sales dollar reaching operations.

The current ratio fell from 0.9x to 0.7x, and FY2026 current liabilities exceeded current assets, leaving a thinner short-term balance-sheet cushion. The $869.1M buyback also reduced the equity cushion despite positive net income, showing that shareholder distributions materially shape financing capacity.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 50 / 100
Financial Health Score 50/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of DocuSign, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
45

DocuSign, Inc. has an operating margin of 9.3%, meaning the company retains $9 of operating profit per $100 of revenue. This results in a moderate score of 45/100, indicating healthy but not exceptional operating efficiency. This is up from 6.7% the prior year.

Growth
60

DocuSign, Inc.'s revenue grew 8.2% year-over-year to $3.2B, a solid pace of expansion. This earns a growth score of 60/100.

Leverage
43

DocuSign, Inc. has a moderate D/E ratio of 1.21. This balance of debt and equity financing earns a leverage score of 43/100.

Liquidity
9

DocuSign, Inc.'s current ratio of 0.73 is below the typical benchmark, resulting in a score of 9/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
95

DocuSign, Inc. converts 32.9% of revenue into free cash flow ($1.1B). This strong cash generation earns a score of 95/100.

Returns
49

DocuSign, Inc.'s ROE of 16.1% shows moderate profitability relative to equity, earning a score of 49/100. This is down from 53.3% the prior year.

Altman Z-Score Safe
3.67

DocuSign, Inc. scores 3.67, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($13.3B) relative to total liabilities ($2.3B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
6/8

DocuSign, Inc. passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
3.77x

For every $1 of reported earnings, DocuSign, Inc. generates $3.77 in operating cash flow ($1.2B OCF vs $309.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
117.27x

DocuSign, Inc. earns $117.27 in operating income for every $1 of interest expense ($298.6M vs $2.5M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$875.7M
YoY+9.4%
QoQ+5.5%
5Y CAGR+11.3%

DocuSign, Inc. generated $875.7M in revenue in Q2 2027. This represents an increase of 9.4% from the same quarter a year earlier. Against the prior quarter it is up 5.5%.

EBITDA
$146.6M
YoY+64.3%
QoQ+2.2%

DocuSign, Inc.'s EBITDA was $146.6M in Q2 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 64.3% from the same quarter a year earlier. Against the prior quarter it is up 2.2%.

Net Income
$77.7M
YoY+23.4%
QoQ-0.6%

DocuSign, Inc. reported $77.7M in net income in Q2 2027. This represents an increase of 23.4% from the same quarter a year earlier. Against the prior quarter it is down 0.6%.

EPS (Diluted)
$0.40
YoY+33.3%
QoQ0.0%

DocuSign, Inc. earned $0.40 per diluted share (EPS) in Q2 2027. This represents an increase of 33.3% from the same quarter a year earlier. It is unchanged from the prior quarter.

Cash & Balance Sheet

Free Cash Flow
$295.8M
YoY+35.9%
QoQ+2.2%
5Y CAGR+12.8%

DocuSign, Inc. generated $295.8M in free cash flow in Q2 2027, representing cash available after capex. This represents an increase of 35.9% from the same quarter a year earlier. Against the prior quarter it is up 2.2%.

Cash & Debt
$528.2M
YoY-12.0%
QoQ-3.6%
5Y CAGR+0.4%

DocuSign, Inc. held $528.2M in cash as of Q2 2027; long-term debt is not reported for that period.

Shares Outstanding
187M
YoY-7.1%
QoQ-2.1%
5Y CAGR-1.0%

DocuSign, Inc. had 187M shares outstanding in Q2 2027. This represents a decrease of 7.1% from the same quarter a year earlier. Against the prior quarter it is down 2.1%.

Dividends Per Share

Not reported for Q2 2027.

Margins & Returns

Gross Margin
79.7%
YoY+0.4pp
QoQ+0.3pp
5Y change+1.9pp

DocuSign, Inc.'s gross margin was 79.7% in Q2 2027, indicating the percentage of revenue retained after direct costs. This is up 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.

Operating Margin
13.4%
YoY+5.3pp
QoQ0.0pp
5Y change+17.8pp

DocuSign, Inc.'s operating margin was 13.4% in Q2 2027, reflecting core business profitability. This is up 5.3 percentage points from the same quarter a year earlier. It is unchanged from the prior quarter.

Net Margin
8.9%
YoY+1.0pp
QoQ-0.6pp
5Y change+13.9pp

DocuSign, Inc.'s net profit margin was 8.9% in Q2 2027, showing the share of revenue converted to profit. This is up 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.6 percentage points.

Return on Equity
4.5%
YoY+1.3pp
QoQ+0.2pp
5Y change+16.6pp

DocuSign, Inc.'s ROE was 4.5% in Q2 2027, measuring profit generated per dollar of shareholder equity. This is up 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.

Capital Allocation

R&D Spending
$163.6M
YoY-3.6%
QoQ+2.5%
5Y CAGR+11.6%

DocuSign, Inc. invested $163.6M in research and development in Q2 2027. This represents a decrease of 3.6% from the same quarter a year earlier. Against the prior quarter it is up 2.5%.

Share Buybacks
$306.5M
YoY+52.1%
QoQ-3.5%

DocuSign, Inc. spent $306.5M on share buybacks in Q2 2027, returning capital to shareholders by reducing shares outstanding. This represents an increase of 52.1% from the same quarter a year earlier. Against the prior quarter it is down 3.5%.

Capital Expenditures
$38.8M
YoY+36.5%
QoQ+20.3%
5Y CAGR+19.5%

DocuSign, Inc. invested $38.8M in capex in Q2 2027, funding long-term assets and infrastructure. This represents an increase of 36.5% from the same quarter a year earlier. Against the prior quarter it is up 20.3%.

DOCU Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DOCU quarterly income statement
MetricQ2'2710-QQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q
Revenue$875.7M+9.4%$830.2M+8.7%$836.9M+7.8%$818.4M+8.4%$800.6M+8.8%$763.7M+7.6%$776.3M+9.0%$754.8M+7.8%
Cost of Revenue$177.9M+7.5%$171.3M+8.9%$169.8M+6.0%$170.5M+8.9%$165.5M+6.4%$157.3M+5.2%$160.2M+8.3%$156.5M+9.7%
Gross Profit$697.9M+9.9%$659.0M+8.7%$667.1M+8.3%$647.8M+8.3%$635.2M+9.4%$606.4M+8.2%$616.0M+9.1%$598.3M+7.3%
R&D Expenses$163.6M-3.6%$159.6M+0.1%$168.3M+8.2%$167.6M+10.9%$169.6M+14.9%$159.4M+18.7%$155.5M+2.6%$151.1M+10.6%
SG&A Expenses$102.7M+8.3%$91.9M+1.8%$105.5M+6.8%$98.3M+0.8%$94.9M+8.9%$90.3M-2.4%$98.8M-3.8%$97.6M-9.9%
Operating Income$117.6M+80.3%$111.3M+84.7%$87.7M+45.1%$85.4M+44.6%$65.2M+12.8%$60.3M+166.3%$60.5M+508.6%$59.0M+199.1%
EBITDA$146.6M+64.3%$143.5M+58.4%$124.0M+39.0%$110.9M+27.9%$89.2M+5.2%$90.6M+92.3%$89.2M+165.5%$86.7M+101.3%
Interest Expense$569K-31.3%$551K+15.3%$586K+46.5%$654K+41.6%$828K+52.2%$478K+231.9%$400K-76.6%$462K-70.7%
Income Tax$47.3M+250.3%$39.6M+2222.9%$11.2M+172.1%$11.8M+29.0%$13.5M+101.7%$1.7M-39.9%-$15.6M-723.9%$9.2M+408.0%
Net Income$77.7M+23.4%$78.2M+8.5%$90.3M+8.2%$83.7M+34.1%$63.0M-92.9%$72.1M+113.5%$83.5M+206.3%$62.4M+60.9%
EPS (Basic)$0.41+32.3%$0.40+14.3%$0.45+7.1%$0.41+32.3%$0.31-92.9%$0.35+118.7%$0.42+223.1%$0.31+63.2%
EPS (Diluted)$0.40+33.3%$0.40+17.6%$0.44+12.8%$0.40+33.3%$0.30-93.0%$0.34+112.5%$0.39+200.0%$0.30+57.9%
Diluted Shares (Avg)193M-8.5%196M-7.7%N/A208M-0.3%211M+1.3%213M+1.4%N/A209M+0.3%

DOCU Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DOCU quarterly balance sheet
MetricQ2'2710-QQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q
Total Assets$4.0B+0.3%$4.0B+0.9%$4.2B+5.4%$4.0B+5.6%$3.9B+5.2%$3.9B+34.9%$4.0B+35.0%$3.8B+13.0%
Current Assets$1.3B-3.8%$1.3B-8.8%$1.5B+0.1%$1.3B-1.9%$1.3B-1.8%$1.4B-7.6%$1.5B-5.0%$1.3B-34.8%
Cash & Equivalents$528.2M-12.0%$548.0M-16.6%$602.4M-7.1%$583.3M-4.5%$600.0M-3.1%$657.4M-19.6%$648.6M-18.6%$610.9M-48.6%
Short-Term Investments$249.5M+2.1%$266.2M-8.6%$264.1M-16.1%$256.6M-22.6%$244.5M-23.4%$291.3M+8.1%$314.9M+26.8%$331.5M-17.5%
Accounts Receivable$370.5M+3.8%$300.7M-2.2%$516.4M+20.2%$355.0M+18.2%$356.9M+15.2%$307.6M+0.5%$429.6M-2.2%$300.4M-16.6%
Long-Term Investments$195.4M-6.4%$209.9M+31.1%$208.4M+55.4%$208.5M+84.9%$208.9M+103.7%$160.1M+15.1%$134.1M+9.9%$112.8M+103.4%
Goodwill$458.4M+0.4%$459.1M+0.9%$458.4M+0.9%$457.2M+0.3%$456.4M+0.2%$455.3M+29.2%$454.5M+28.7%$455.7M+29.6%
Total Liabilities$2.2B+14.3%$2.2B+12.0%$2.3B+15.0%$2.0B+12.3%$2.0B+9.5%$1.9B+8.0%$2.0B+9.1%$1.8B-24.9%
Current Liabilities$2.0B+11.1%$1.9B+8.4%$2.0B+11.3%$1.8B+11.6%$1.8B+10.5%$1.7B+8.5%$1.8B+10.3%$1.6B-27.0%
Non-Current Liabilities$269.2M+45.1%$275.7M+44.2%$272.3M+52.9%$216.8M+19.1%$185.5M+0.1%$191.2M+3.5%$178.1M-1.6%$182.1M-0.7%
Total Equity$1.7B-13.6%$1.8B-9.7%$1.9B-4.2%$2.0B-0.4%$2.0B+1.4%$2.0B+77.2%$2.0B+77.3%$2.0B+106.1%
Retained Earnings-$2.3B-51.3%-$2.1B-49.9%-$1.9B-44.2%-$1.7B-38.0%-$1.5B-39.8%-$1.4B+21.6%-$1.3B+22.9%-$1.2B+28.7%

Not reported in any period shown, so not listed: Inventory, Long-Term Debt.

DOCU Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DOCU quarterly cash flow statement
MetricQ2'2710-QQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q
Operating Cash Flow$334.5M+36.0%$321.7M+27.9%$377.2M+22.5%$290.3M+23.9%$246.1M+11.7%$251.4M-1.3%$307.9M+13.7%$234.3M-11.3%
Depreciation & Amortization$29.0M+20.8%$32.2M+6.1%$26.4M-7.9%$25.5M-7.7%$24.0M-11.0%$30.4M+23.9%$28.7M+21.5%$27.6M+18.5%
Stock-Based CompensationN/A$141.4M-2.9%N/AN/AN/A$145.6M+2.2%N/AN/A
Capital Expenditures$38.8M+36.5%$32.3M+36.5%$27.0M-4.7%$27.4M+15.9%$28.4M+27.6%$23.6M+3.8%$28.3M+28.2%$23.6M-1.0%
Free Cash Flow$295.8M+35.9%$289.4M+27.0%$350.2M+25.3%$262.9M+24.8%$217.6M+10.0%$227.8M-1.8%$279.6M+12.5%$210.7M-12.3%
Investing Cash Flow-$6.9M+77.4%-$39.2M-57.5%-$33.7M-4.2%-$37.7M+13.6%-$30.5M+82.7%-$24.9M+59.0%-$32.3M-148.0%-$43.7M-227.5%
Financing Cash Flow-$345.1M-26.3%-$334.4M-49.6%-$332.6M-43.7%-$270.5M-36.4%-$273.3M-14.3%-$223.5M-31.6%-$231.5M+68.5%-$198.3M-64.2%
Share Buybacks$306.5M+52.1%$317.5M+73.1%$269.1M+66.4%$215.1M+24.6%$201.5M+0.7%$183.4M+23.1%$161.7M$172.7M+130.1%

Not reported in any period shown, so not listed: Dividends Paid.

DOCU Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DOCU quarterly financial ratios
MetricQ2'2710-QQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q
Gross Margin79.7%+0.4pp79.4%0.0pp79.7%+0.4pp79.2%-0.1pp79.3%+0.5pp79.4%+0.5pp79.4%+0.1pp79.3%-0.4pp
Operating Margin13.4%+5.3pp13.4%+5.5pp10.5%+2.7pp10.4%+2.6pp8.2%+0.3pp7.9%+4.7pp7.8%+6.4pp7.8%+5.0pp
Net Margin8.9%+1.0pp9.4%0.0pp10.8%0.0pp10.2%+2.0pp7.9%9.4%+4.7pp10.8%+6.9pp8.3%+2.7pp
Return on Equity4.5%+1.3pp4.3%+0.7pp4.7%+0.5pp4.2%+1.1pp3.2%-42.1pp3.6%+0.6pp4.2%+1.8pp3.1%-0.9pp
Return on Assets2.0%+0.4pp2.0%+0.1pp2.1%+0.1pp2.1%+0.4pp1.6%-22.1pp1.8%+0.7pp2.1%+1.2pp1.7%+0.5pp
Current Ratio0.64-0.1x0.66-0.1x0.73-0.1x0.73-0.1x0.74-0.1x0.79-0.1x0.81-0.1x0.83-0.1x
Debt-to-Equity1.30+0.3x1.19+0.2x1.21+0.2x1.01+0.1x0.99+0.1x0.96-0.6x1.00-0.6x0.90-1.6x
Asset Turnover0.220.0x0.210.0x0.200.0x0.210.0x0.200.0x0.190.0x0.190.0x0.200.0x
FCF Margin33.8%+6.6pp34.9%+5.0pp41.9%+5.8pp32.1%+4.2pp27.2%+0.3pp29.8%-2.9pp36.0%+1.1pp27.9%-6.4pp

Note: The current ratio is below 1.0 (0.73), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
DocuSign, Inc. DOCU FY2026 $3.2B $309.1M 9.6% $13.3B 50/100
Bentley Systems, Incorporated BSY FY2025 $1.5B $277.9M 18.5% $10.5B 61/100
Dynatrace, Inc. DT FY2026 $2.0B $163.0M 8.1% $17.7B 67/100
GUIDEWIRE SOFTWARE, INC. GWRE FY2026 $1.5B $139.3M 9.4% $13.5B 58/100
Manhattan Associates Inc MANH FY2025 $1.1B $219.9M 20.3% $12.1B 68/100
PAYCOM SOFTWARE, INC. PAYC FY2025 $2.1B $453.4M 22.1% $10.4B 63/100

Frequently Asked Questions

What is DocuSign, Inc.'s annual revenue?

DocuSign, Inc. (DOCU) reported $3.2B in total revenue for fiscal year 2026. This represents a 8.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is DocuSign, Inc.'s revenue growing?

DocuSign, Inc. (DOCU) revenue grew by 8.2% year-over-year, from $3.0B to $3.2B in fiscal year 2026.

Is DocuSign, Inc. profitable?

Yes, DocuSign, Inc. (DOCU) reported a net income of $309.1M in fiscal year 2026, with a net profit margin of 9.6%.

DocuSign, Inc. (DOCU) reported diluted earnings per share of $1.48 for fiscal year 2026. This represents a -70.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

DocuSign, Inc. (DOCU) had EBITDA of $414.7M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

DocuSign, Inc. (DOCU) had a gross margin of 79.4% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

DocuSign, Inc. (DOCU) had an operating margin of 9.3% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

DocuSign, Inc. (DOCU) had a net profit margin of 9.6% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

DocuSign, Inc. (DOCU) has a return on equity of 16.1% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

DocuSign, Inc. (DOCU) generated $1.1B in free cash flow during fiscal year 2026. This represents a 15.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

DocuSign, Inc. (DOCU) generated $1.2B in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

DocuSign, Inc. (DOCU) had $4.2B in total assets as of fiscal year 2026, including both current and long-term assets.

DocuSign, Inc. (DOCU) invested $106.4M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

DocuSign, Inc. (DOCU) invested $665.0M in research and development during fiscal year 2026.

Yes, DocuSign, Inc. (DOCU) spent $869.1M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

DocuSign, Inc. (DOCU) had 194M shares outstanding as of fiscal year 2026.

DocuSign, Inc. (DOCU) had a current ratio of 0.73 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.

DocuSign, Inc. (DOCU) had a debt-to-equity ratio of 1.21 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

DocuSign, Inc. (DOCU) had a return on assets of 7.3% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

DocuSign, Inc. (DOCU) trades at 40.3x earnings, its market capitalization divided by net income of $330.0M net income, trailing 12 months to July 31, 2026. The market capitalization is $13.3B as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

DocuSign, Inc. (DOCU) trades at 4.0x sales, its market capitalization divided by revenue of $3.4B revenue, trailing 12 months to July 31, 2026. The market capitalization is $13.3B as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

DocuSign, Inc. (DOCU) has an Altman Z-Score of 3.67, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

DocuSign, Inc. (DOCU) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

DocuSign, Inc. (DOCU) has an earnings quality ratio of 3.77x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

DocuSign, Inc. (DOCU) has an interest coverage ratio of 117.27x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

DocuSign, Inc. (DOCU) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top